Skip to content

Clinical trials

Heart Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Country / region: Russia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20091
20101
20112
20124
20131
20181
20191
20201
20212
20231
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting5
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Efferon JSC2
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia2
GlaxoSmithKline2
Amarin Pharma Inc.1
AstraZeneca1
Bayer1
CSL Behring1
Cardium Therapeutics1
Carelon Research1
I.M. Sechenov First Moscow State Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases24
Cardiovascular Diseases10
Coronary Artery Disease8
Coronary Disease6
Acute Coronary Syndrome4
Heart Failure4
Myocardial Ischemia4
Angina Pectoris3
Atherosclerosis3
Stroke3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.